Due to their reported contribution to various processes in cancerogenesis and malignant progression, KCa3.1 channels are being increasingly explored in several cancer entities [1,2] such as leukemia [3,4], glioblastoma [5,6] as well as in gynecological cancers [7,8]. This evidence concerns the gene KCNN4 and glioblastoma.